Rosane G. De Paula Queiroz

3900, Bandeirantes Avenue
Ribeirao Preto, SP 14049900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies.

Therapeutic Potential of Targeting USP2 in Pediatric Group 3 and 4 Medulloblastomas: Insights from In Silico, Ex Vivo, and In Vitro Studies.

Journal: Cerebellum (London, England)

Published: May 18, 2026

AFG2B gene variants and elevated protein expression in lupus nephritis: new insights into childhood-onset systemic lupus erythematosus.

AFG2B gene variants and elevated protein expression in lupus nephritis: new insights into childhood-onset systemic lupus erythematosus.

Journal: Advances in rheumatology (London, England)

Published: June 18, 2025

miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma.

miR-512-3p as a Potential Biomarker of Poor Outcome in Pediatric Medulloblastoma.

Journal: Cerebellum (London, England)

Published: February 25, 2025

Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells.

Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells.

Journal: Human cell

Published: June 05, 2023

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.

Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas.

Journal: Cancer gene therapy

Published: December 21, 2022

Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Journal: Cellular and molecular neurobiology

Published: July 13, 2021

A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.

A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: July 10, 2020

Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus.

Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus.

Journal: Arthritis research & therapy

Published: September 04, 2019

Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup.

Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup.

Journal: Scientific reports

Published: July 29, 2019

A simplified approach using Taqman low-density array for medulloblastoma subgrouping.

A simplified approach using Taqman low-density array for medulloblastoma subgrouping.

Journal: Acta neuropathologica communications

Published: January 22, 2019

Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.

Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines.

Journal: Journal of neuro-oncology

Published: January 02, 2018

Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.

Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.

Journal: Journal of neuro-oncology

Published: December 11, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026